The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
Open accessAbstract
Background Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS). We assessed the epidemiology of SARS in Hong Kong.Methods We included 1425 cases reported up to April 28, 2003. An integrated database was constructed from several sources containing information on epidemiological, demographic, and clinical variables. We estimated the key epidemiological distributions: infection to onset, onset to admission, admission to death, and admission to discharge. We measured associations between the estimated case fatality rate and patients' age and the time from onset to admission.Findings After the initial phase of exponential growth, the rate of confirmed cases fell to less than 20 per day by April 28. Public-health interventions included encouragement to report to hospital rapidly after the onset of clinical symptoms, contact tracing for confirmed and suspected cases, and quarantining, monitoring, and restricting the travel of contacts. The mean incubation period of the disease is estimated to be 6.4 days (95% CI 5.2-7.7). The mean time from onset of clinical symptoms to admission to hospital varied between 3 and 5 days, with longer times earlier in the epidemic. The estimated case fatality rate was 13.2% (9.8-16.8) for patients younger than 60 years and 43.3% (35.2-52.4) for patients aged 60 years or older assuming a parametric gamma distribution. A non-parametric method yielded estimates of 6.8% (4.0-9.6) and 55.0% (45.3-64.7), respectively. Case clusters have played an important part in the course of the epidemic.Interpretation Patients' age was strongly associated with outcome. The time between onset of symptoms and admission to hospital did not alter outcome, but shorter intervals will be important to the wider population by restricting the infectious period before patients are placed in quarantine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there were substantial variations among studies, with no clear indication of what factors might drive such heterogeneity (appendix 1 pp 58, 65), except that the delay reduced over time because of improved population awareness.75”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916
Self-citationA Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
Severe acute respiratory syndrome (SARS) in Hong Kong
TSANG, K. W. T., Mok, T., Wong, P. C., & OOI, G. C. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00486.x · Cited by 19
Cited by
Sorted by citations
Items 901–932 of 932
Jin, A., & Sharifi, H. (2022) · medRxiv · doi:10.1101/2022.10.23.22281416
“Numerous respiratory pandemics have occurred over the last several decades and have offered opportunities for the scientific and healthcare community to develop effective methods for resource deployment (27,28).”
BackgroundPoutanen, S. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00222-6
El síndrome respiratorio agudo severo y su relación con los factores de riesgo proximales y distales
Chancay, F. (2022) · Revista GICOS · doi:10.53766/gicos/2022.07.01.14
“…grave e incluso tratada como insuficiencia multiorgánica durante la etapa tardía de la enfermedad, aunque según diversas investigaciones como las de Donnelly et al. (2003) y Li et al. (2003) reflejaban la aparición de distintos factores de riesgo asociados, originados a raíz de su propagación y…”
BackgroundInnate immune responses in COVID-19
Jacotot, E. D., Talamini, L., Bonam, S. R., Vieira, A. T., Frémeaux‐Bacchi, V., Radic, M. Z., Dragon‐Durey, M., Lozano, J. M., Saia, R. S., & Muller, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00041-4
Epidemiology and virology of SARS-CoV-2
Leung, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95059-6.00008-5
“The data of 1425 SARS-CoV cases in Hong Kong suggest a case-fatality rate of 13% for patients younger than 60 years of age but 43% for those aged 60 years or above, In addition, approximately 25% of patients with SARS-CoV developed severe respiratory failure [26].”
BackgroundAranguiz, P. (2021) · Revista Geográfica de Chile Terra Australis · doi:10.23854/07199562.2021571.aranguiz53
Jin, A., & Sharifi, H. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.46.007413
Şahin, E. Ö., & Köroğlu, M. (2023) · doi:10.59537/saupress.2337
Rahman, F. U., Owais, M., Uddin, S., Rahman, A., Gul, N., Tayyeb, M., Rahman, A. U., Ali, N., Jadoon, M. A., & Khan, H. U. (2022) · Journal of Khyber College of Dentistry · doi:10.33279/jkcd.v12i1.75
Chaudhry, D., Singh, P. K., & Govindagoudar, M. B. (2023) · doi:10.1093/med/9780198766438.003.0039
Hua, Y., Zhou, Y., Qin, Z., Mu, Y., Wang, T., & Ruan, H. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s447326
“41,42 Besides, SARS-CoV-2 indirectly causes renal damage through cytokine storms and activation of coagulation pathways, and leads to sepsis, hemodynamic instability, and hypoxemia.”
BackgroundBylica, I., Gajda, M., Rudzińska, A. K., Jachowicz-Matczak, E., Heczko, P. B., Brodowicz, J., Gawlik, K., Pawlica-Gosiewska, D., Solnica, B., Kliś-Kalinowska, A., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4825095
Yalçınkaya, Ü. L., Sütçü, C., & Eken, İ. (2024) · The Turkish Online Journal of Design Art and Communication · doi:10.7456/tojdac.1473413
UNVEILING THE PATHOPHYSIOLOGICAL LANDSCAPE OF COVID-19: INSIGHTS FOR NOVEL THERAPEUTIC STRATEGIES
Iqbal, L., Iqbal, N., & Khan, M. (2024) · Pakistan Journal of Scientific Research · doi:10.57041/pjosr.v4i1.1132
“The common symptoms appearing in patients aged 40-60 years are fever, general body pain, dry cough, breathlessness and sometimes pneumonia in immuno compromised individuals or people battling an ongoing underlying disease [12], [13].”
BackgroundThe importance of the incubation time distribution in compartmental epidemiological models
Rozan, E., Kuperman, M. N., & Bouzat, S. (2024) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2024.129998
“However, it has been suggested that a Gamma-type distributions fit field observations much better [8, 9, 10, 11, 12, 13, 14, 15, 16].”
BackgroundRole of ACE Inhibitors and Angiotensin Receptor Blockers in Covid19 Patients
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_9 · Cited by 1
Mulondo, J., Nayiga, S., Nuwagaba, W., Nayebare, P., Namuganga, J. F., Ssewanyana, I., Kamya, M. R., & Nankabirwa, J. I. (2024) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0758
“29,30 Modeling studies have shown that case identi fi cation and isolation may reduce the incidence and transmission of COVID-19 infection.”
Molecular Epidemiological Analysis of SARS-CoV
Tehseen, S., Muntaha, S.-T., Khan, M. S., Saeed, M., Naveed, M., Safdar, M., Hussain, F., & Younas, U. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274943124010004
Iqbal, M. Z., Majeed, M. B. B., Saeed, M., Safdar, M., Rahim, K., Hussain, F., Majeed, H., & Younas, U. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274943124010003
Prêcheur, I., Benhamou, Y., & Pakdaman, L. (2020) · Ortho magazine · doi:10.1016/s1262-4586(22)00035-8
Estimating the effect of contact tracing during the early stage of an epidemic
Wang, M., Ma, J., den Driessche, P. V., & Cowen, L. L. E. (2025) · Infectious Disease Modelling · doi:10.1016/j.idm.2025.02.005
“The SARS virus spread to more than 30 countries and regions in 2002 e 2003 (Dye & Gay, 2003).”
Transmission Waiting Time: A Unifying Metric for Outbreak ControllabilityPreprint
Shin, C. Y., Park, S. W., Viboud, C. G., Sabeti, P. C., Fraser, C., & Sun, K. (2025) · medRxiv · doi:10.1101/2025.10.18.25338292
“This pattern stands in stark contrast to SARS-CoV-1, for which the incubation period is shorter than the transmission waiting time (Figure 3(A), inset), consistent with SARS-CoV-1’s minimal presymptomatic transmission [52].”
Self-citationQiu, W.-J., Chen, W., Shi, X.-L., & Zhang, J. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.130039
Flexible school attendance strategies for epidemic outbreaks: simulation-based decision support
Takahashi, S., Kitazawa, M., & Yoshikawa, A. (2025) · BMC Public Health · doi:10.1186/s12889-025-25197-4
“The following month, Donnelly et al. [58] analyzed the epidemiological determinants of SARS-CoV-1 transmission in Hong Kong and also reported that the median incubation period ranged from 4 to 6 days.”
Zhang, S., Zhu, Q., Zhan, C., Cheng, W., Mingfang, X., Fang, M., & Fang, L. (2020) · Figshare · doi:10.6084/m9.figshare.12885967
Additional file 1 of A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
Torneri, A., Libin, P., Vanderlocht, J., Vandamme, A.-M., Neyts, J. H., & Hens, N. (2020) · Figshare · doi:10.6084/m9.figshare.12569318
Post-infection and post-vaccination anti-COVID-19 antibody levels in relation to physical condition
Bylica, I., Gajda, M., Rudzińska, A. K., Jachowicz-Matczak, E., Brodowicz, J., Kliś-Kalinowska, A., Pietrzyk, A., Romaniszyn, D., Gawlik, K., Pawlica-Gosiewska, D., et al. (2026) · Journal of Public Health · doi:10.1007/s10389-025-02665-0
Perrier, A. (2019) · theses.fr (ABES) · doi:10.70675/68da4238zea7cz4ed3z8cc0z4df6aa8c5c3d · Cited by 7
“The estimated fatality rate for patients under 60 years is around 7-13%, but for patients over 60 years it goes up to 43-55% (Donnelly et al., 2003).”
Background(2026) · Elsevier eBooks · doi:10.1016/b978-0-44-355525-1.00020-5
The history of pandemics and epidemiological modeling
Lazebnik, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-44-355525-1.00007-2
BindingDB (2013) · UC San Diego · doi:10.7270/q2qf8tz4
Metadata
- Authors
- Donnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., Chan, K.-P., Lam, T.-H., Tse, L.-Y., Tsang, T., Liu, S.-H., Kong, J. H., Lau, E. M., Ferguson, N. M., & Anderson, R. M.
- Affiliations
- Imperial College London (GB)
- University of Hong Kong (HK)
- Department of Health (CN)
- Hospital Authority (HK)
- Chinese University of Hong Kong (HK)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 361
- Issue
- 9371
- Pages
- 1761-1766
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7112380
- OpenAlex
- W1990049863
- Cited by
- 940
- References
- 3
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 15 · 2023: 18 · 2022: 39 · 2021: 93 · 2020: 154 · 2019: 18 · 2018: 5 · 2017: 10 · 2016: 15 · 2015: 17 · 2014: 15 · 2013: 20 · 2012: 9
- FWCI
- 71.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- Royal Society
- Medical Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS, Hong Kong SARS outbreak, incubation period, case fatality rate, age and mortality, contact tracing, quarantine, public health interventions, case clusters, infectious period
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Disease Outbreaks, Female, Hong Kong, Humans, Infant, Male, Middle Aged, Quarantine, Incidence, Survival Rate, Likelihood Functions, Age Distribution, Disease Progression, Severe Acute Respiratory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review